| Zugriffe | |
|---|---|
| A Randomized, Double‐Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid Arthritis | 94 |
| März 2025 | April 2025 | Mai 2025 | Juni 2025 | Juli 2025 | August 2025 | September 2025 | |
|---|---|---|---|---|---|---|---|
| A Randomized, Double‐Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid Arthritis | 7 | 2 | 4 | 4 | 8 | 0 | 0 |
| Zugriffe | |
|---|---|
| 2020_Burmester_etal.pdf | 94 |
